Amporin Pharmaceuticals
Amporin Pharmaceuticals aims to develop a new class of small-molecule drugs that block and eliminate toxic soluble oligomers and pores from within cell membranes.
Visit websiteBasel, Switzerland
Healthtech
Funding summary
- Total raised
- €157K
- Funding rounds
- 1
Investors in Amporin Pharmaceuticals
Investors on record for Amporin Pharmaceuticals. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Amporin Pharmaceuticals?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors